EKOS has secured CE mark for its EKOS EkoSonic Endovascular System, an endovascular device approved for the treatment of pulmonary embolism (PE).

The EkoSonic System, designed and approved to dissolve blood clots in the arms and legs, has the added indication for treating this major unmet medical need.

EKOS president and CEO Robert Hubert said the CE mark is an important milestone for EKOS and a clear demonstration of their ongoing commitment to champion a better solution for treatment of PE.

EKOS claims that its EkoSonic System provides a new life saving therapy for PE patients.

Principal investigator of the Ultrasound Accelerated Thrombolysis of Pulmonary Embolism (ULTIMA) trial Nils Kucher said as the EKOS system incorporates into the catheter body small ultrasound transmitters which condition the clot to more rapidly absorb the thrombolytic drug, it can dissolve the clot faster than thrombolytic drug alone.